R&D Performance, Collaborative Arrangements and the Market for Know-How: A Test of the "Lemons" Hypothesis in Biotechnology
Preprint
- 1 January 1997
- preprint
- Published by Elsevier in SSRN Electronic Journal
Abstract
This paper examines the relative performance of vertically integrated projects versus collaborative projects in the bio-pharmaceuticals industry. Using Akerlof'Keywords
This publication has 23 references indexed in Scilit:
- When is Virtual Virtuous? Organizing for InnovationPublished by World Scientific Pub Co Pte Ltd ,2003
- The First Biopharmaceuticals Approved in the United States: 1980-1994Drug Information Journal, 1996
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- TECHNOLOGY ACQUISITION AND THE CHOICE OF GOVERNANCE BY ESTABLISHED FIRMS: INSIGHTS FROM OPINION THEORY IN A MULTINOMIAL LOGIT MODEL.Academy of Management Proceedings, 1994
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- Absorptive Capacity: A New Perspective on Learning and InnovationAdministrative Science Quarterly, 1990
- Strategic Partnering and Technological Co-OperationPublished by Springer Nature ,1990
- Project Scope and Project Performance: The Effect of Parts Strategy and Supplier Involvement on Product DevelopmentManagement Science, 1989
- Becoming PALs: Pooling, Allying, and Linking Across CompaniesAcademy of Management Perspectives, 1989
- The Market for "Lemons": Quality Uncertainty and the Market MechanismThe Quarterly Journal of Economics, 1970